Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus

被引:142
作者
Song, Yun-Mi
Sung, Joohon
Yang, Soonha
Choe, Yon Ho
Chang, Yun Sil
Park, Won Soon
机构
[1] Sungkyunkwan Univ, Sch Med, Samsun Med Ctr, Dept Family Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Clin Res Ctr, Dept Family Med, Seoul, South Korea
[3] Kangwon Natl Univ, Coll Med, Dept Prevent Med, Kangwan, South Korea
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea
[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea
关键词
disease transmission; vertical; hepatitis B; hepatitis B e antigens; hepatitis B surface antigens;
D O I
10.1007/s00431-006-0327-5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
In spite of adequate immunoprophylaxis, perinatal transmission of hepatitis B virus (HBV) has not been completely eliminated. This study evaluated the factors associated with the failure of HBV immunoprophylaxis. The study participants were 144 children who were born to HBsAg-seropositive mothers of known HBeAg status and they had received HB immune globulin and HB vaccine within 24 hours after birth followed by two further administrations of HB vaccine as recommended. Seventeen of the children (11.8%) suffered immunoprophylaxis failure, defined by HBsAg-seropositivity. The rate of HBV immunoprophylaxis failure was 12%, 0%, 21%, 0%, and 27% among the children born to HBsAg-seropositive, HBeAg-seronegative, HBeAg-seropositive, undetectable HBV DNA, and detectable HBV DNA mothers, respectively. The failure of HBV immunoprophylaxis was significantly associated with maternal HBeAg-seropositivity and HBV DNA seropositivity. To identify those children at high risk of HBV immunoprophylaxis failure, maternal HBeAg and HBV DNA need to be assessed prior to childbirth.
引用
收藏
页码:813 / 818
页数:6
相关论文
共 20 条
[1]  
Ahn Yoon-Ok, 1992, Seoul Journal of Medicine, V33, P105
[2]  
BEASLEY RP, 1983, LANCET, V2, P1099
[3]   FAILURE OF NEONATAL HEPATITIS-B VACCINATION - THE ROLE OF HBV-DNA LEVELS IN HEPATITIS-B CARRIER MOTHERS AND HLA ANTIGENS IN NEONATES [J].
DELCANHO, R ;
GROSHEIDE, PM ;
SCHALM, SW ;
DEVRIES, RRP ;
HEIJTINK, RA .
JOURNAL OF HEPATOLOGY, 1994, 20 (04) :483-486
[4]   Ten-year neonatal hepatitis B vaccination program, the Netherlands, 1982-1992: protective efficacy and long-term immunogenicity [J].
delCanho, R ;
Grosheide, PM ;
Mazel, JA ;
Heijtink, RA ;
Hop, WCJ ;
Gerards, LJ ;
deGast, GC ;
Fetter, WPF ;
Zwijneberg, J ;
Schalm, SW .
VACCINE, 1997, 15 (15) :1624-1630
[5]   Chronic maternal hepatitis B infection and premature rupture of membranes [J].
Fiore, AE .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (04) :357-358
[6]   Epidemiology of hepatitis B infection in the Western Pacific and South East Asia [J].
Gust, ID .
GUT, 1996, 38 :S18-S22
[7]   Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers [J].
Hill, JB ;
Sheffield, JS ;
Kim, MJ ;
Alexander, JM ;
Sercely, B ;
Wendel, GD .
OBSTETRICS AND GYNECOLOGY, 2002, 99 (06) :1049-1052
[8]  
IP HMH, 1989, LANCET, V1, P406
[9]   Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea [J].
Lee, DH ;
Kim, JH ;
Nam, JJ ;
Kim, HR ;
Shin, HR .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2002, 17 (04) :457-462
[10]   PREVENTION OF MATERNAL-INFANT HEPATITIS-B VIRUS TRANSMISSION BY IMMUNIZATION - THE ROLE OF SERUM HEPATITIS-B VIRUS-DNA [J].
LEE, SD ;
LO, KJ ;
WU, JC ;
TSAI, YT ;
WANG, JY ;
TING, LP ;
TONG, MJ .
HEPATOLOGY, 1986, 6 (03) :369-373